# Adverse events and tolerability of ketogenic diets – a systematic literature analysis

**Authors:** Carolin Schopf, Marc Assmann, Nadja Wolke, Marius Frenser, Thorsten Marquardt, Tobias Fischer

PMC · DOI: 10.1186/s40795-026-01277-5 · BMC Nutrition · 2026-02-20

## TL;DR

This study reviews the side effects of ketogenic diets and finds that gastrointestinal issues are most common, with stricter diets causing more severe problems.

## Contribution

The paper provides a systematic analysis of adverse events associated with ketogenic diets, highlighting their frequency and diversity.

## Key findings

- Gastrointestinal issues were the most common adverse events, affecting 40% of participants.
- Stricter ketogenic diets were associated with higher rates and severity of adverse events.
- Constipation was the most frequently reported individual adverse event, affecting 24% of participants.

## Abstract

Ketogenic diets (KDs) are becoming increasingly popular in the treatment of various diseases, not just pharmacoresistant epilepsy. Despite the growing use of this dietary approach and its economic rationale, a systematic overview of the associated adverse events remains conspicuously absent.

A systematic literature search was conducted in accordance with PRISMA guidelines in the electronic database PubMed. Prospective interventional studies documenting adverse events associated with ketogenic diets published between 2019 and 2024 were included. The recorded adverse events were categorized according to CTCAE criteria and analyzed based on frequency and diversity by diet type.

A total of 36 studies involving 42 ketogenic interventions (classic KD, modified Atkins diet, MCT-based KD, LGIT) were evaluated. The included studies covered a wide range of age groups and conditions. At least one adverse event was documented in 43% of the participants (0–89%, 0.91 ± 0.71 adverse events per person). The most prevalent adverse events were gastrointestinal (40%), followed by neurological (17%), and metabolic and nutritional (12%) disorders. Constipation (24%) was the most commonly reported individual adverse event. A higher rate and severity of adverse events was observed in patients following stricter diets. The tolerability of the intervention was influenced by several factors, including age, the presence of underlying diseases, and the duration of the intervention.

The analysis indicates that adverse events frequently occur alongside KD and encompass a broad spectrum, with gastrointestinal complaints predominating. However, the significance of the findings is limited by the heterogeneity of dietary regimens, the lack of standardization, and the occasional inadequate documentation of adverse events. In clinical practice, it is recommended that adverse events are recorded systematically and monitored regularly.

## Linked entities

- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}
- **Diseases:** headaches (MESH:D006261), PDH deficiency (MESH:D015325), liver disease (MESH:D008107), gastrointestinal symptoms (MESH:D012817), muscle cramps (MESH:D009120), diseases (MESH:D004194), somnolence (MESH:D006970), hypoproteinemia (MESH:D007019), reflux (MESH:D005764), presyncope (MESH:D013575), epilepsy (MESH:D004827), symptoms (MESH:D012816), dystonia (MESH:D004421), respiratory symptoms (MESH:D012818), optic neuropathy (MESH:D009901), dyslipidemia (MESH:D050171), eczema (MESH:D004485), MAD (MESH:C538195), sleep disturbances (MESH:D012893), Keto flu (MESH:D007251), lack of (MESH:D001259), growth retardation (MESH:D006130), back pain (MESH:D001416), mitochondrial diseases (MESH:D028361), atherosclerotic (MESH:D050197), dysmenorrhea (MESH:D004412), hypomagnesemia (OMIM:613882), Parkinson's (MESH:D010300), Infections (MESH:D007239), hypoglycemia (MESH:D007003), insomnia (MESH:D007319), carnitine deficiency (MESH:C536778), NAFLD (MESH:D065626), Cardiovascular AEs (MESH:D002318), Psychiatric symptoms (MESH:D001523), bad breath (MESH:D012120), colitis (MESH:D003092), gallstones (MESH:D042882), cancer (MESH:D009369), Gastrointestinal (MESH:D005767), AEs (MESH:D064420), dermatological (MESH:D000168), granulocyte (MESH:D007960), lethargy (MESH:D053609), abdominal pain (MESH:D015746), Weight loss (MESH:D015431), cardiac arrest (MESH:D006323), dehydration (MESH:D003681), kidney stones (MESH:D007669), dizziness (MESH:D004244), pancreatitis (MESH:D010195), electrolyte (MESH:D014883), anxiety (MESH:D001007), anorexia (MESH:D000855), osteopenia (MESH:D001851), Musculoskeletal (MESH:D009140), Weight gain (MESH:D015430), dry mouth (MESH:D014987), vitamin and mineral deficiencies (MESH:C537337), type 2 diabetes (MESH:D003924)
- **Chemicals:** MAD (-), BHB (MESH:D020155), fat (MESH:D005223), vitamin D (MESH:D014807), Ketone (MESH:D007659), valproic acid (MESH:D014635), AcAc (MESH:C016635), selenium (MESH:D012643), carbohydrate (MESH:D002241), acetone (MESH:D000096), fatty acid (MESH:D005227), MCT (MESH:C000709826), Ketone bodies (MESH:D007657), magnesium (MESH:D008274), calcium (MESH:D002118), blood glucose (MESH:D001786)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930977/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930977/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930977/full.md

---
Source: https://tomesphere.com/paper/PMC12930977